Characteristic | Barberry group (n = 42) | Control group (n = 42) | P-Valuea | |
---|---|---|---|---|
Age (years) | 53.62 ± 10.34 | 54.50 ± 10.13 | 0.69 | |
Sex (male) | 22 (52.4%) | 16 (38.1%) | 0.18 | |
Diabetes | 14 (33.3%) | 14 (33.3%) | 1 | |
Dyslipidemia | 30 (71.4%) | 27 (64.2%) | 0.64 | |
Smoking | 15 (35.7%) | 12 (28.6%) | 0.48 | |
Statins drugs use | Â | Â | 0.98 | |
  none | 13 (30.9%) | 13 (30.9%) |  | |
  Rosuvastatin 5 or Atorvastatin 10 | 4 (9.5%) | 3 (7.1%) |  | |
  Rosuvastatin 10 or Atorvastatin 20 | 11 (26.1%) | 11 (26.1%) |  | |
  Rosuvastatin 20 or Atorvastatin 40 | 12 (28.5%) | 13 (30.9%) |  | |
Weight (Kg) | Before | 79.91 ± 13.52 | 75.42 ± 10.05 | 0.08 |
After 2-month | 79.71 ± 13.27 | 75.46 ± 9.93 | 0.10 | |
BMI (Kg/m2) | Before | 28.21 ± 2.03 | 27.83 ± 2.32 | 0.42 |
After 2-month | 28.16 ± 1.96 | 27.85 ± 2.30 | 0.51 | |
Phisical activity (MET-hr/d) | Before | 27.0 ± 3.85 | 26.61 ± 3.62 | 0.64 |
After 2-month | 27.38 ± 3.95 | 26.76 ± 3.90 | 0.47 |